DK1521600T3 - Bisacyloxypropylcystein-konjugat og anvendelse heraf - Google Patents
Bisacyloxypropylcystein-konjugat og anvendelse herafInfo
- Publication number
- DK1521600T3 DK1521600T3 DK03765055T DK03765055T DK1521600T3 DK 1521600 T3 DK1521600 T3 DK 1521600T3 DK 03765055 T DK03765055 T DK 03765055T DK 03765055 T DK03765055 T DK 03765055T DK 1521600 T3 DK1521600 T3 DK 1521600T3
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- ooc
- coo
- polyoxyethylene
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02016066A EP1382352A1 (fr) | 2002-07-19 | 2002-07-19 | Conjugués de bisacylpropylcystéine et leur utilisation |
| PCT/EP2003/007892 WO2004009125A2 (fr) | 2002-07-19 | 2003-07-18 | Conjugues de bisacyloxypropylcysteine et leur utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1521600T3 true DK1521600T3 (da) | 2008-06-09 |
Family
ID=29762661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03765055T DK1521600T3 (da) | 2002-07-19 | 2003-07-18 | Bisacyloxypropylcystein-konjugat og anvendelse heraf |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7316996B2 (fr) |
| EP (3) | EP1382352A1 (fr) |
| AT (1) | ATE385422T1 (fr) |
| AU (1) | AU2003251002B2 (fr) |
| CA (1) | CA2489010C (fr) |
| CY (1) | CY1107929T1 (fr) |
| DE (1) | DE50309128D1 (fr) |
| DK (1) | DK1521600T3 (fr) |
| ES (1) | ES2301832T3 (fr) |
| HK (1) | HK1074802A1 (fr) |
| PT (1) | PT1521600E (fr) |
| SI (1) | SI1521600T1 (fr) |
| WO (1) | WO2004009125A2 (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19652586A1 (de) * | 1996-12-17 | 1998-06-18 | Biotechnolog Forschung Gmbh | Dhc-Peptid und Mittel |
| US7573421B2 (en) | 2001-09-24 | 2009-08-11 | Nice Systems, Ltd. | System and method for the automatic control of video frame rate |
| EP1484064A1 (fr) * | 2003-06-04 | 2004-12-08 | Gesellschaft für Biotechnologische Forschung | Composition thérapeutique contenant des cellules dendritiques et son utilisation |
| EP1776963A1 (fr) | 2005-10-19 | 2007-04-25 | Gbf-Gesellschaft Für Biotechnologische Forschung Mbh | Hexosylcéramides comme adjuvants et leurs utilisations dans des compositions pharmaceutiques |
| EP1782826A1 (fr) | 2005-11-08 | 2007-05-09 | GBF Gesellschaft für Biotechnologische Forschung mbH | PQS, c-diGMP et leurs conjugués utilisés comme adjuvants et leur emploi dans des compositions pharmaceutiques |
| EP1787660A1 (fr) * | 2005-11-22 | 2007-05-23 | GBF Gesellschaft für Biotechnologische Forschung mbH | Nouveaux adjuvants a base des conjugés de bisacyloxypropylcystéine et leurs utilisations en compositions pharmaceutiques |
| EP1897557A1 (fr) * | 2006-09-07 | 2008-03-12 | Helmholtz-Zentrum für Infektionsforschung GmbH | Utilisation des glycolipides comme adjuvant immunologique |
| DE102006045453A1 (de) * | 2006-09-26 | 2008-04-03 | Khs Ag | Transportsystem |
| EP2196196A1 (fr) * | 2008-12-10 | 2010-06-16 | Medipol S.A. | Composé, médicament, composition de vaccin et nanocapsules |
| EP2305283A1 (fr) | 2009-09-24 | 2011-04-06 | Helmholtz-Zentrum für Infektionsforschung GmbH | Compositions pharmaceutiques pour traiter les maladies inflammatoires dérégulées |
| EP2338521A1 (fr) * | 2009-12-28 | 2011-06-29 | Helmholtz-Zentrum für Infektionsforschung GmbH | Conjugués de lipopeptide et de lipoprotéine et leur utilisation |
| US8808703B2 (en) * | 2010-03-23 | 2014-08-19 | Tom Yao-Hsiang Wu | Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc |
| PL2618842T3 (pl) | 2010-09-22 | 2019-10-31 | Ena Therapeutics Pty Ltd | Nowa metoda immunostymulacyjna |
| WO2012041503A1 (fr) | 2010-09-30 | 2012-04-05 | Franvax S.R.L. | Production de particules de virosome |
| EP2522350B1 (fr) | 2011-05-12 | 2013-07-31 | Immunopharm AG | Utilisation de la combinaison de matière active constituée d'un dérivé de 1-diéthylaminoéthyle-3-chinoxaline-2-one et d'un oxystérol pour la rupture des résistances dans des traitements du cancer et pour l'augmentation de la capacité immunitaire lors de cancers, de maladies bactériennes ou virales, de maladies auto-immunes, d'effets de stress ou de pollution environnementale |
| KR20160102210A (ko) | 2013-12-27 | 2016-08-29 | 노버스 인터내쇼날 인코포레이티드 | 에톡시화 계면활성제 |
| US10584306B2 (en) | 2017-08-11 | 2020-03-10 | Board Of Regents Of The University Of Oklahoma | Surfactant microemulsions |
| CN114174260A (zh) | 2019-06-26 | 2022-03-11 | 阿克塞利阿肿瘤学私人有限公司 | 新型分子 |
| CN115501125A (zh) * | 2022-10-20 | 2022-12-23 | 澳门科技大学 | 用于修复皮肤损伤的h2s供体凝胶及h2s供体凝胶制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595732A (en) * | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
| US5580563A (en) * | 1992-05-01 | 1996-12-03 | Tam; James P. | Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof |
| AU666789B2 (en) * | 1992-12-28 | 1996-02-22 | Takeda Chemical Industries Ltd. | 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof |
| EP0604945A1 (fr) * | 1992-12-28 | 1994-07-06 | Takeda Chemical Industries, Ltd. | TAN-1511, dérivés, préparation et utilisation |
| CA2128552A1 (fr) * | 1993-07-22 | 1995-01-23 | Hida Tsuneaki | Derives de l'acide 6,7-dihydroxy-4-thiaheptanoique et leur utilisation |
| DE19652586A1 (de) * | 1996-12-17 | 1998-06-18 | Biotechnolog Forschung Gmbh | Dhc-Peptid und Mittel |
| WO2000042175A1 (fr) * | 1999-01-14 | 2000-07-20 | Bolder Biotechnology Inc. | Techniques permettant de produire des proteines contenant des residus cysteine libres |
-
2002
- 2002-07-19 EP EP02016066A patent/EP1382352A1/fr not_active Withdrawn
-
2003
- 2003-07-18 US US10/521,013 patent/US7316996B2/en not_active Expired - Lifetime
- 2003-07-18 AU AU2003251002A patent/AU2003251002B2/en not_active Ceased
- 2003-07-18 SI SI200331197T patent/SI1521600T1/sl unknown
- 2003-07-18 DE DE50309128T patent/DE50309128D1/de not_active Expired - Lifetime
- 2003-07-18 PT PT03765055T patent/PT1521600E/pt unknown
- 2003-07-18 CA CA2489010A patent/CA2489010C/fr not_active Expired - Fee Related
- 2003-07-18 ES ES03765055T patent/ES2301832T3/es not_active Expired - Lifetime
- 2003-07-18 DK DK03765055T patent/DK1521600T3/da active
- 2003-07-18 AT AT03765055T patent/ATE385422T1/de active
- 2003-07-18 EP EP08002115A patent/EP1955713A1/fr not_active Withdrawn
- 2003-07-18 EP EP03765055A patent/EP1521600B1/fr not_active Expired - Lifetime
- 2003-07-18 WO PCT/EP2003/007892 patent/WO2004009125A2/fr active IP Right Grant
-
2005
- 2005-10-07 HK HK05108901A patent/HK1074802A1/xx not_active IP Right Cessation
-
2008
- 2008-05-02 CY CY20081100473T patent/CY1107929T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004009125A2 (fr) | 2004-01-29 |
| ES2301832T3 (es) | 2008-07-01 |
| US20060134061A1 (en) | 2006-06-22 |
| PT1521600E (pt) | 2008-05-13 |
| US7316996B2 (en) | 2008-01-08 |
| ATE385422T1 (de) | 2008-02-15 |
| AU2003251002A1 (en) | 2004-02-09 |
| SI1521600T1 (sl) | 2008-08-31 |
| AU2003251002B2 (en) | 2009-02-26 |
| CA2489010A1 (fr) | 2004-01-29 |
| EP1382352A1 (fr) | 2004-01-21 |
| DE50309128D1 (de) | 2008-03-20 |
| CA2489010C (fr) | 2012-01-17 |
| EP1955713A1 (fr) | 2008-08-13 |
| EP1521600A2 (fr) | 2005-04-13 |
| WO2004009125A3 (fr) | 2004-05-27 |
| HK1074802A1 (en) | 2005-11-25 |
| EP1521600B1 (fr) | 2008-02-06 |
| CY1107929T1 (el) | 2013-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1074802A1 (en) | Bisacyloxypropylcysteine conjugates and the use thereof | |
| CY1119848T1 (el) | Απομονωμενη τετραμερικη ουρικαση | |
| CA2063886A1 (fr) | Proteines conjuguees au polyethylene | |
| WO2006059029A3 (fr) | Solutions viscoelastiques renfermant du hyaluronate de sodium et de l'hydroxypropylmethyl- cellulose, preparation et utilisations | |
| CA2203480A1 (fr) | Conjugues de l'interferon | |
| HRP20070432B1 (hr) | Gastrorezistentne farmaceutske formulacije koje sadrže rifamicin | |
| MXPA04004025A (es) | Conjugados polimericos de acido retinoico solubles en agua. | |
| WO2005028539A3 (fr) | Promedicaments a base de polymere a branches multiples | |
| EP2626368A3 (fr) | Conjugués insuline-oligomère, formulations et utilisations de ceux-ci | |
| WO2000064486A3 (fr) | Conjugues de medicaments polymeres actives par voie enzymatique | |
| HUP0103003A2 (hu) | PEG/karbamát oxidáz konjugátumok és alkalmazásuk | |
| CA2371871A1 (fr) | Fixation de stent par modification de ballonnet | |
| ATE380023T1 (de) | Orale feste pharmazeutische zusammensetzungen zur ph-abhängig mehrphasigen freisetzung | |
| WO1990015628A1 (fr) | Conjugue polymere antibiotique | |
| AU2002215904A1 (en) | Compounds with a branched linker | |
| IS6879A (is) | Neublastín sem tengt er fjölliðu og aðferðir við notkun þess | |
| TR199902775T2 (xx) | 20(S)-Kamptotesin glikokonjugeleri. | |
| AU1373197A (en) | Covalent lipid-phosphonocarboxylic acid conjugates, the production thereof as well as their use as antiviral pharmaceutical agents | |
| TWI266801B (en) | Polyol-IFN-beta conjugates | |
| CY1114005T1 (el) | Συζευγματα peg-ουρικης οξειδασης και χρηση αυτων |